Management of hypercortisolism;Prise en charge d'un hypercorticisme

Revue de Medecine Interne

Volumn 29, Issue 4, 2008, Pages 337-346

  Rosales, C ^a   Fierrard, H ^c,d,e   Bertagna, X ^c,d,e   Raffin Sanson, M L ^a,b,c,d  

^a HÔPITAL AMBROISE PARÉ   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c INSTITUT COCHIN   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Institut Cochin   (France)

Author keywords

Cushing's syndrome; Hypercortisolism

Indexed keywords

CARBAMAZEPINE; CORTICOTROPIN; DESMOPRESSIN; DEXAMETHASONE; DIGOXIN; GADOLINIUM; GLITAZONE DERIVATIVE; GLYCYRRHETINIC ACID; KETOCONAZOLE; MITOTANE; RETINOIC ACID; SOMATOSTATIN DERIVATIVE;

ACTH SECRETING ADENOMA; ALCOHOL CONSUMPTION; BLOOD ANALYSIS; CARDIOVASCULAR RISK; CAVERNOUS SINUS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DATA BASE; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ECTOPIC CORTICOTROPIN PRODUCTION; HORMONE RELEASE; HUMAN; HYPERCORTISOLISM; HYPOPHYSIS; IMAGING SYSTEM; KIDNEY FAILURE; MEDLINE; MENTAL DISEASE; OBESITY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PATIENT REFERRAL; SALIVA ANALYSIS; SCINTIGRAPHY; SHORT SURVEY; SURGEON; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT PLANNING;

ANTINEOPLASTIC AGENTS, HORMONAL; CUSHING SYNDROME; DECISION TREES; ENZYME INHIBITORS; HUMANS; HYPOPHYSECTOMY; KETOCONAZOLE; MITOTANE; PITUITARY GLAND;

EID: 41049094383     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.11.007     Document Type: Short Survey

References (42)

1. Boscaro M., Barzon L., Fallo F., and Sonino N. Cushing's syndrome. Lancet 357 (2001) 783-791
2. Lindholm J., Juul S., Jorgensen L., Astrup J., Bjerre P., Feldt-Rasmussen U., et al. Incidence and late prognosis of Cushing's syndrome: a population-based study. J Clin Endocrinol Metab 86 (2001) 117-123
3. Newell-Price J., Bertagna X., Grossman A.B., and Nieman L.K. Cushing's syndrome. Lancet 367 (2006) 1605-1617
4. Catargi B., Rigalleau V., Poussin A., Ronci-Chaix N., Bex V., Vergnot V., et al. Occult Cushing's syndrome in type-2 diabetes. J Clin Endocrinol Metab 88 (2003) 5808-5813
5. Colao A., Pivonello R., Spiezia S., Faggiano A., Ferone D., Filippella M., et al. Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure. J Clin Endocrinol Metab 84 (1999) 2664-2672
6. Faggiano A., Pivonello R., Spiezia S., De Martino M.C., Filippella M., Di Somma C., et al. Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission. J Clin Endocrinol Metab 88 (2003) 2527-2533
7. Newell-Price J., Trainer P., Besser M., and Grossman A. The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocr Rev 19 (1998) 647-672
8. Orth D.N. Cushing's syndrome. N Engl J Med 332 (1995) 791-803
9. Vestergaard P., Lindholm J., Jorgensen J.O.L., Hagen C., Hoeck H.C., Lauberg P., et al. Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146 (2002) 51-56
10. Magiakou M.A., Mastorakos G., Oldfield E.H., Gomez M.T., Doppman J.L., Cutler G.B., et al. Cushing's syndrome in children and adolescents-Presentation, diagnosis, and Therapy. N Engl J Med 331 (1994) 629-636
11. Leibowitz G., Tsur A., Chayen S.D., Salameh M., Raz I., Cerasi E., et al. Pre-clinical Cushing's syndrome: an unexpected frequent cause of poor glycemic control in obese diabetic patients. Clin Endocrinol (Oxf) 44 6 (1996) 717-722
12. Reimondo G., Pia A., Allasino B., Tassone F., Bovio S., Borretta G., et al. Screening of Cushing's syndrome in adult patients with newly diagnosed diabetes mellitus. Clin Endocrinol (Oxf) 67 (2007) 225-229
13. Rossi R., Tauchmanova L., Luciano A., Di Martino M., Battista C., Del Viscovo L., et al. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features. J Clin Endocrinol Metab 85 (2000) 1440-1448
14. Libè R., Dall'Asta C., Barbetta L., Baccarelli A., Beck-Peccoz P., and Ambrosi B. Long-term follow-up study of patients with adrenal incidentalomas. Eur J Endocrinol 147 (2002) 489-494
15. Arnaldi G., Angeli A., Atkinson B., Bertagna X., Cavagnini F., Chrousos P., et al. Diagnosis and complications of Cushing's syndrome: a consensus statement. J Clin Endocrinol Metab 88 (2003) 5593-5602
16. Ambrosi B., Bochicchio D., Ferrario R., Colombo P., and Faglia G. Screening tests for Cushing's syndrome. Clin Endocrinol (Oxf) 33 (1990) 809-811
17. Findling J.W., Hershel R., and Aron D.C. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J Clin Endocrinol Metab 89 (2004) 1222-1226
18. Isidori A.M., Kaltsas G.A., Mohammed S., Morris D.G., Jenkins P., Chew S.L., et al. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. J Clin Endocrinol Metab 88 (2003) 5299-5306
19. Yaneva M., Mosnier-Pudar H., Dugue M.A., Grabar S., Fulla Y., and Bertagna X. Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes. J Clin Endocrinol Metab 89 (2004) 3345-3351
20. Viardot A., Huber P., Puder J.J., Zulewski H., Keller U., and Müller B. Reproducibility of nighttime salivary cortisol and its use in the diagnosis of hypercortisolism compared with urinary free cortisol and overnight dexamethasone suppression test. J Clin Endocrinol Metab. 90 (2005) 5730-5736
21. Moro M., Putignano P., Losa M., Invitti C., Maraschini C., and Cavagnini F. The desmopressin test in the differential diagnosis between Cushing's disease and pseudo-Cushing states. J Clin Endocrinol Metab 85 (2000) 3569-3574
22. Newell-Price J., Morris D.G., Drake W.M., Korbonits M., Monson J.P., Besser G.M., et al. Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing's syndrome. J Clin Endocrinol Metab 87 (2002) 1640-1645
23. Rockall A.G., Babar S.A., Sohaib S.A.A., Isidori A.M., Diaz-Cano S., Monson J.P., et al. CT and MR imaging of the adrenal glands in ACTH-independent Cushing syndrome. Radiographics 24 (2004) 435-452
24. Invitti C., Percori Giraldi F., De Martin M., and Cavagnini F. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study group of the Italian society of endocrinology on the pathophysiology of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab 84 (1999) 440-448
25. Hall W.A., Luciano M.G., Doppman N.J., and Oldfield E.H. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med 120 (1994) 817-820
26. Colao A., Faggiano A., Pivonello R., Pecori Giraldi F., and Lombardi F.G. Inferior petrosal samping in the differential diagnosis of Cushing's syndrome: results of an Italian multicenter study. Eur J Endocrinol 144 (2001) 499-507
27. Lindsay J.R., and Nieman L.K. Differential diagnosis and imaging in Cushing's syndrome. Endocrinol Metab Clin North Am 34 (2005) 403-421
28. Phlipponneau M., Nocaudie M., Epelbaum J., De Keyzer Y., Lalau J.D., Marchandise X., et al. Somatostatin analogs for the localization and preoperative treatment of an adrenocorticotropin-secreting bronchial carcinoid tumor. J Clin Endocrinol Metab 78 (1994) 20-24
29. Tsagarakis S., Christoforaki M., Giannopoulou H., Rondogianni F., Housianakou I., Malagari C., et al. A reappraisal of the utility of somatostatin receptor scintigraphy in patients with ectopic adrenocorticotropin Cushing's syndrome. J Clin Endocrinol Metab 88 (2003) 4754-4758
30. Pacak K., Ilias I., Chen C.C., Carrasquillo J.A., Whatley M., and Nieman L.K. The role of [(18)F]fluorodeoxyglucose positron emission tomography and [(111)In]-diethylenetriaminepentaacetate-D-Phe-pentetreotide scintigraphy in the localization of ectopic adrenocorticotropin-secreting tumors causing Cushing's syndrome. J Clin Endocrinol Metab 89 (2004) 2214-2221
31. Orlefors H., Sundin A., Garske U., Juhlin C., Oberg K., Skogseid B., et al. Whole-body (11)C-5-hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 90 (2005) 3392-3400
32. Hammer G.D., Tyrrell J.B., Lamborn K.R., Applebury C.B., Hannegan E.T., Bell S., et al. Transsphenoidal microsurgery for Cushing's disease: initial outcome and long-term results. J Clin Endocrinol Metab 89 (2004) 6348-6357
33. Pereira A.M., van Aken M.O., van Dulken H., Schutte P.J., Biermasz N.R., Smit J.W., et al. Long-term predictive value of postsurgical cortisol concentrations for cure and risk of recurrence in Cushing's disease. J Clin Endocrinol Metab 88 (2003) 5858-5864
34. Estrada J., Boronat M., Mielgo M., Magallón R., Millan I., Díez S., et al. The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing's disease. N Engl J Med 336 (1997) 172-177
35. Nieman L.K. Medical therapy of Cushing's disease. Pituitary 5 (2002) 77-82
36. Heaney A.P., Fernando M., Yong W.H., and Melmed S. Functional PPAR-gamma receptor is a novel therapeutic target for ACTH-secreting pituitary adenomas. Nat Med 8 (2002) 1281-1287
37. Suri D., and Weiss R.E. Effect of pioglitazone on adrenocorticotropic hormone and cortisol secretion in Cushing's disease. J Clin Endocrinol Metab 90 (2005) 1340-1346
38. Van der Hoek J., van der Lelij A.J., Feelders R.A., de Herder W.W., Uitterlinden P., Poon K.W., et al. The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5. Eur J Endocrinol 152 (2005) 645-654
39. Vella A., Thompson G.B., Grant S., van Heerden J.A., Farley D.R., and Young Jr. W.F. Laparoscopic adrenalectomy for adrenocorticotropin-dependent Cushing's syndrome. J Clin Endocrinol Metab 86 (2001) 1596-1599
40. Assie G., Bahurel H., Bertherat J., Kujas M., Legmann P., and Bertagna X. The Nelson's syndrome revisited. Pituitary 7 (2004) 209-215
41. Chavez-Rodriguez J., and Pasieka J.L. Adrenal lesions assessed in the era of laparoscopic adrenalectomy: a modern day series. Am J Surg 189 (2005) 581-586
42. Dackiw A.P., Lee J.E., Gagel J.F., and Evans D.B. Adrenal cortical carcinoma. World J Surg 25 (2001) 914-926